© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
March 19th 2021, 3:00pm
From the first COVID-19 vaccine doses becoming available for patients and their caregivers at a cancer center in Texas to community police officers delivering food to families impacted by cancer in Philadelphia, here’s what’s happening in the cancer landscape this week.
February 27th 2021, 4:00pm
Over the past decade, advances in both diagnostics and therapeutics in a variety of blood cancers have turned certain diseases into chronic conditions.
February 22nd 2021, 2:00pm
Patients with chronic myeloid leukemia are living longer, some even stopping treatment, thanks to a plethora of targeted therapies.
February 19th 2021, 8:00pm
Oncologists and researchers are racing to identify new therapies to help better treat a rare form of acute lymphoblastic leukemia.
February 12th 2021, 1:00pm
Blood shortages during the COVID-19 pandemic have forced cancer centers to get creative to ensure patients with hematologic malignancies are able to get transfusions in a timely manner.
February 10th 2021, 10:00pm
The Food and Drug Administration has granted the investigational therapy asciminib a breakthrough therapy designation for the treatment of certain adults with Philadelphia chromosome-positive chronic myeloid leukemia. The designation may allow for expedited review of the drug.
January 8th 2021, 4:00pm
From one leukemia survivor organizing essential blood drives for patients with cancer as COVID-19 delays hit, to a kindergarten teacher handling a recurrence of ovarian cancer by continuing to teach her students through Zoom, here’s what’s happening in the cancer landscape this week.
December 19th 2020, 12:25am
The Food and Drug Administration approved the supplemental new drug application for Iclusig (ponatinib) to treat patients with chronic-phase chronic myeloid leukemia (CML) with resistance or intolerance to at least two prior kinase inhibitors.
December 4th 2020, 8:00pm
Emily Whitehead was the first child to receive chimeric antigen receptor (CAR)-T cell therapy. Eight years later, she and her parents discuss her ongoing remission from acute lymphoblastic leukemia.
December 4th 2020, 4:00pm
From a recently published study showing preliminary connections between elevated levels of stress-related hormones and cancer recurrence, to a Texas mayor receiving a diagnosis of cancer and COVID-19, here’s what’s happening in the cancer landscape this week.
How Can Cancer Survivors Help The Newly Diagnosed?
CURE Honors World Ovarian Cancer Day
Derazantinib May Demonstrate Promising Disease Control in Some Patients With Cholangiocarcinoma
You May Have Second Thoughts When Receiving a Cancer Diagnosis